Publikationen, an denen er mitarbeitet María Sanjurjo Sáez (97)

2023

  1. Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors

    European Journal of Hospital Pharmacy

  2. Appropriateness of Empirical Antibiotic Therapy for Cervicitis and Urethritis Prescribed in the Emergency Department

    Hospital Pharmacy, Vol. 58, Núm. 1, pp. 106-110

  3. Hacia la excelencia en la atención farmacéutica al paciente quirúrgico

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 1, pp. 26-30

  4. Presence of metallic components in transdermal drug delivery systems and risk of skin burns

    Farmacia Hospitalaria

  5. Remdesivir and SARS-CoV-2 monoclonal antibodies to prevent COVID-19 progression in hematological patients: an observational study

    Pharmacological Reports, Vol. 75, Núm. 5, pp. 1254-1264

2022

  1. A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital

    Frontiers in Public Health, Vol. 10

  2. Dolutegravir-Based Dual Therapies in HIV Pretreated Patients: A Real-Life Study in Madrid

    Annals of Pharmacotherapy, Vol. 56, Núm. 4, pp. 401-411

  3. Implementation and evaluation of a home pharmaceutical care model through Telepharmacy

    Farmacia Hospitalaria, Vol. 46, pp. 36-46

  4. Mobile Apps for Hematological Conditions: Review and Content Analysis Using the Mobile App Rating Scale

    JMIR mHealth and uHealth, Vol. 10, Núm. 2

  5. PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort

    Biomedicine and Pharmacotherapy, Vol. 146

  6. Patient-reported outcomes y aplicaciones móviles. Revisión de su impacto en los resultados en salud de los pacientes

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 3, pp. 173-181

  7. Thalidomide as treatment of refractory thoracic Rosai-Dorfman disease

    Journal of Clinical Pharmacy and Therapeutics, Vol. 47, Núm. 4, pp. 548-551

2021

  1. Chimeric Antigen Receptor T Cell Therapy Management and Safety: A Practical Tool From a Multidisciplinary Team Perspective

    Frontiers in Oncology, Vol. 11

  2. Clinical evaluation of pulmonary hypertension using patient-reported outcomes: a cross-sectional study

    BMC Pulmonary Medicine, Vol. 21, Núm. 1

  3. Dpyd exome, mrna expression and uracil levels in early severe toxicity to fluoropyrimidines: An extreme phenotype approach

    Journal of Personalized Medicine, Vol. 11, Núm. 8

  4. La importancia de los casos clínicos para la Farmacia Hospitalaria

    Revista Española de Casos Clínicos en Medicina Interna (RECCMI), Vol. 6, Núm. 2, pp. 1-1

  5. Levels of tacrolimus after treatment for chronic hepatitis C with direct antiviral agents in solid organ transplant recipients

    International Journal of Clinical Pharmacy, Vol. 43, Núm. 3, pp. 731-736

  6. Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease

    Journal of Oncology Pharmacy Practice, Vol. 27, Núm. 3, pp. 751-755

2020

  1. Assessing apps for patients with genitourinary tumors using the mobile application rating scale (MARS): Systematic search in app stores and content analysis

    JMIR mHealth and uHealth, Vol. 8, Núm. 7

  2. Design of the functional requirements of a smartphone app for patients receiving oral antineoplastic agents: The e-OncoSalud® app

    Journal of Oncology Pharmacy Practice, Vol. 26, Núm. 1, pp. 105-115